CSC may express CD133 at a higher level than the normal progenitors cells, which indeed has been shown in colorectal, pancreatic, gastric, and hepatocellular carcinomas [82] thus leading to more toxicity in target cells than in physiologic progenitors. The gene discussed is PROM1; the disease is hepatocellular carcinoma.